Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-04-04

Clinical Trial Update: Study of Quality of Life in Freeman-Sheldon Syndrome and Related Conditions

View source ↗

Summary

This clinical trial update notes that the study evaluating quality of life in Freeman-Sheldon syndrome and related conditions has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Freeman-Sheldon Research Group, Inc. | Conditions: Arthrogryposis, Craniofacial Abnormalities | Status: TERMINATED